{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T07:04:59Z","timestamp":1792134299507,"version":"4.4.0"},"reference-count":40,"publisher":"Japanese Society of Internal Medicine","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,11,15]]},"DOI":"10.2169\/internalmedicine.4945-24","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T18:09:36Z","timestamp":1744394976000},"page":"3244-3251","source":"Crossref","is-referenced-by-count":3,"title":["Early-onset Colorectal Cancer in a Patient with Li-Fraumeni Syndrome: A Case Series and Literature Review"],"prefix":"10.2169","volume":"64","author":[{"given":"Kazuki","family":"Sekiguchi","sequence":"first","affiliation":[{"name":"Center for Clinical Training, Toyama University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iori","family":"Motoo","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Ando","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Noguchi","sequence":"additional","affiliation":[{"name":"Diagnostic Pathology, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rei","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Toyama University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Nomura","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurika","family":"Nakayama","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Kajiura","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Ueda","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuno","family":"Goto","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seitarou","family":"Shimada","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Takashima","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeko","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"Fujinami","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Yasuda","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Kumamoto T, Yamazaki F, Nakano Y, et al. Medical guidelines for Li-Fraumeni syndrome 2019, version 1.1. Int J Clin Oncol 26: 2161-2178, 2021.","DOI":"10.1007\/s10147-021-02011-w"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kratz CP, Achatz MI, Brugieres L, et al. Cancer screening recommendations for individuals with Li-Fraumeni syndrome. Clin Cancer Res 23: 38-45, 2017.","DOI":"10.1158\/1078-0432.CCR-17-0408"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Funato M, Tsunematsu Y, Yamazaki F, et al. Characteristics of Li-Fraumeni syndrome in Japan; a review study by the special committee of JSHT. Cancer Sci 112: 2821-2834, 2021.","DOI":"10.1111\/cas.14919"},{"key":"4","unstructured":"4. The <i>TP53<\/i> database of the US National Cancer Institute [Internet]. Available from: https:\/\/tp53.isb-cgc.org\/"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. MacFarland SP, Zelley K, Long JM, et al. Earlier colorectal cancer screening may be necessary in patients with Li-Fraumeni syndrome. Gastroenterology 156: 273-274, 2019.","DOI":"10.1053\/j.gastro.2018.09.036"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Wong P, Verselis SJ, Garber JE, et al. Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome. Gastroenterology 130: 73-79, 2006.","DOI":"10.1053\/j.gastro.2005.10.014"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Bougeard G, Renaux-Petel M, Flaman JM, et al. Revisiting Li-Fraumeni syndrome from <i>TP53<\/i> mutation carriers. J Clin Oncol 33: 2345-2352, 2015.","DOI":"10.1200\/JCO.2014.59.5728"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Matsuoka T, Shinozaki H, Ozawa H, et al. Juvenile rectal cancer in a family with Li-Fraumeni syndrome. Nihon Shokaki Geka Gakkai Zasshi (Jpn J Gastroenterol Surg) 49: 1170-1178, 2016 (in Japanese).","DOI":"10.5833\/jjgs.2015.0230"},{"key":"9","unstructured":"9. Suzuki O, Amano K, Chika N, et al. Report of multidisciplinary treatment for sisters with Li-Fraumeni syndrome. Gan To Kagaku Ryoho (Jpn J Cancer Chemother) 49: 1947-1949, 2022 (in Japanese, Abstract in English)."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Rengifo-Cam W, Shepherd HM, Jasperson KW, et al. Colon pathology characteristics in Li-Fraumeni syndrome. Clin Gastroenterol Hepatol 16: 140-141, 2018.","DOI":"10.1016\/j.cgh.2017.06.017"},{"key":"11","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.3332\/ecancer.2022.1487","volume":"16","author":"RP Riechelmann","year":"2022","unstructured":"11. Riechelmann RP, Soares DC, Dias C, Carraro DM, Torrezan GT. Li-Fraumeni-associated pancreatic neuroendocrine tumour and XAF1 p.Glu134Ter risk modifier variant. Ecancermedicalscience 16: 1487, 2022.","journal-title":"ecancermedicalscience","ISSN":"https:\/\/id.crossref.org\/issn\/1754-6605","issn-type":"print"},{"key":"12","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s12885-020-06723-6","volume":"20","author":"JG Aversa","year":"2020","unstructured":"12. Aversa JG, De Abreu FB, Yano S, et al. The first pancreatic neuroendocrine tumor in Li-Fraumeni syndrome: a case report. BMC Cancer 20: 256, 2020.","journal-title":"BMC Cancer","ISSN":"https:\/\/id.crossref.org\/issn\/1471-2407","issn-type":"print"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Al Mansor E, Adamiak A, Asmis T. Li-Fraumeni syndrome with unusual synchronous malignancies: a case report. Case Rep Oncol 17: 49-55, 2024.","DOI":"10.1159\/000535099"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Rengifo-Cam W, Shepherd HM, Jasperson KW, et al. Colon pathology characteristics in Li-Fraumeni syndrome. Clin Gastroenterol Hepatol 16: 140-141, 2018.","DOI":"10.1016\/j.cgh.2017.06.017"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Malkin D, Li FP, Strong LC, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250: 1233-1238, 1990.","DOI":"10.1126\/science.1978757"},{"key":"16","unstructured":"16. Li FP, Fraumeni JF Jr, Mulvihill JJ, et al. A cancer family syndrome in twenty-four kindreds. Cancer Res 48: 5358-5362, 1988."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Landrum MJ, Lee JM, Benson M, et al. ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Res 44: D862-D868, 2016.","DOI":"10.1093\/nar\/gkv1222"},{"key":"18","unstructured":"18. Frebourg T, Barbier N, Yan YX, et al. Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome. Am J Hum Genet 56: 608-615, 1995."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Rausch T, Jones DT, Zapatka M, et al. Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with <i>TP53<\/i> mutations. Cell 148: 59-71, 2012.","DOI":"10.1016\/j.cell.2011.12.013"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Fortes FP, Kuasne H, Marchi FA, et al. DNA methylation patterns of candidate genes regulated by thymine DNA glycosylase in patients with <i>TP53<\/i> germline mutations. Braz J Med Biol Res 48: 610-615, 2015.","DOI":"10.1590\/1414-431x20154026"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Sun J, Meng H, Yao L, et al. Germline mutations in cancer susceptibility genes in a large series of unselected breast cancer patients. Clin Cancer Res 23: 6113-6119, 2017.","DOI":"10.1158\/1078-0432.CCR-16-3227"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Nandikolla AG, Venugopal S, Anampa J. Breast cancer in patients with Li-Fraumeni syndrome - a case-series study and review of literature. Breast Cancer (Dove Med Press) 9: 207-215, 2017.","DOI":"10.2147\/BCTT.S134241"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 408: 307-310, 2000.","DOI":"10.1038\/35042675"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Guha T, Malkin D. Inherited <i>TP53<\/i> mutations and the Li-Fraumeni syndrome. Cold Spring Harb Perspect Med 7: a026187, 2017.","DOI":"10.1101\/cshperspect.a026187"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Yurgelun MB, Masciari S, Joshi VA, et al. Germline <i>TP53<\/i> mutations in patients with early-onset colorectal cancer in the Colon Cancer Family Registry. JAMA Oncol 214-221, 2015.","DOI":"10.1001\/jamaoncol.2015.0197"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Ruijs MW, Verhoef S, Rookus MA, et al. <i>TP53<\/i> germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes. J Med Genet 47: 421-428, 2010.","DOI":"10.1136\/jmg.2009.073429"},{"key":"27","unstructured":"27. Nichols KE, Malkin D, Garber JE, Fraumeni JF Jr, Li FP. Germ-line <i>p53<\/i> mutations predispose to a wide spectrum of early-onset cancers. Cancer Epidemiol Biomarkers Prev 10: 83-87, 2001."},{"key":"28","doi-asserted-by":"publisher","unstructured":"28. Kawasaki K, Toshimitsu K, Matano M, et al. An organoid biobank of neuroendocrine neoplasmas enables genotype-phenotype mapping. Cell 183: 1420-1435, 2020.","DOI":"10.1016\/j.cell.2020.10.023"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Capdevila J, Arques O, Mora JRH, et al. Epigenetic <i>EGFR<\/i> gene repression confers sensitivity to therapeutic BRAFV600E blockade in colon neuroendocrine carcinomas. Clin Cancer Res 26: 902-909, 2020.","DOI":"10.1158\/1078-0432.CCR-19-1266"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Venizelos A, Elvebakken H, Perren A, et al. The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms. Endocr Relat Cancer 29: 1-14, 2021.","DOI":"10.1530\/ERC-21-0152"},{"key":"31","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature11252","volume":"487","author":"DM Muzny","year":"2012","unstructured":"31. Muzny DM, Bainbridge MN, Chang K, et al. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487: 330-337, 2012.","journal-title":"?Nature","ISSN":"https:\/\/id.crossref.org\/issn\/0028-0836","issn-type":"print"},{"key":"32","unstructured":"32. Yoshimura J, Natsumeda M, Nishihira Y, et al. Radiation-induced intracranial osteosarcoma after radiation for acute lymphocytic leukemia associated with Li-Fraumeni syndrome. No Shinkei Geka (Neurol Surg) 41: 499-505, 2013 (in Japanese, Abstract in English)."},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Izawa N, Matsumoto S, Manabe J, et al. A Japanese patient with Li-Fraumeni syndrome who had nine primary malignancies associated with a germline mutation of the <i>p53<\/i> tumor-suppressor gene. Int J Clin Oncol 13: 78-82, 2008.","DOI":"10.1007\/s10147-007-0692-8"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Yamada H, Shinmura K, Yamamura Y, et al. Identification and characterization of a novel germline <i>p53<\/i> mutation in a patient with glioblastoma and colon cancer. Int J Cancer 125: 973-976, 2009.","DOI":"10.1002\/ijc.24432"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Masuda T, Souda H, Takiguchi N, Tonooka T, Yamamoto H, Miyazaki M. Anal canal cancer with pagetoid spread in a patient with Li-Fraumeni syndrome. Nihon Rinsho Geka Gakkai Zasshi (J Jpn Surg Assoc) 75: 1647-1652, 2014 (in Japanese, Abstract in English).","DOI":"10.3919\/jjsa.75.1647"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Yoshida T, Tajika M, Tanaka T, et al. The features of colorectal tumors in a patient with Li-Fraumeni syndrome. Intern Med 56: 295-300, 2017.","DOI":"10.2169\/internalmedicine.56.7274"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Iwasaki M, So C, Jinta T. Identification of a <i>TP53<\/i> mutation in a patient with Li-Fraumeni syndrome and not meeting the revised Chompret criteria: a case report. Cureus 15: e40025, 2023.","DOI":"10.7759\/cureus.40025"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Une M, Fujiwara R, Ueki A, et al. A case of sequential medical therapy for advanced ureteral cancer in Li-Fraumeni syndrome. IJU Case Rep 6: 286-289, 2023.","DOI":"10.1002\/iju5.12607"},{"key":"39","unstructured":"39. Oliver M, Goldgar DE, Sodha N, et al. Li-Fraumeni and related syndrome: correlation between tumor type, family structure, <i>TP53<\/i> genotype. Cancer Res 63: 6643-6650, 2003."},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Bougeard G, Sesboue R, Baert DS, et al. Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families. J Med Genet 45: 535-538, 2008.","DOI":"10.1136\/jmg.2008.057570"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/22\/64_4945-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T03:27:25Z","timestamp":1763177245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/22\/64_4945-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,15]]},"references-count":40,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4945-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,15]]},"article-number":"4945-24"}}